BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 27878291)

  • 1. Adenovirus-mediated truncated Bid overexpression induced by the Cre/LoxP system promotes the cell apoptosis of CD133+ ovarian cancer stem cells.
    Long Q; Yang R; Lu W; Zhu W; Zhou J; Zheng C; Zhou D; Yu L; Wu J
    Oncol Rep; 2017 Jan; 37(1):155-162. PubMed ID: 27878291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Truncated Bid Overexpression Induced by Recombinant Adenovirus Cre/LoxP System Suppresses the Tumorigenic Potential of CD133
    Long Q; Zhu W; Zhou J; Wu J; Lu W; Zheng C; Zhou D; Yu L; Yang R
    Oncol Res; 2017 Apr; 25(4):595-603. PubMed ID: 27760587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Truncated Bid Regulates Cisplatin Response via Activation of Mitochondrial Apoptosis Pathway in Ovarian Cancer.
    Dai Y; Zhao XJ; Li F; Yuan Y; Yan DM; Cao H; Huang XY; Hu Z; Ma D; Gao QL
    Hum Gene Ther; 2020 Mar; 31(5-6):325-338. PubMed ID: 32024383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An adenovirus encoding proapoptotic Bax induces apoptosis and enhances the radiation effect in human ovarian cancer.
    Arafat WO; Gómez-Navarro J; Xiang J; Barnes MN; Mahasreshti P; Alvarez RD; Siegal GP; Badib AO; Buchsbaum D; Curiel DT; Stackhouse MA
    Mol Ther; 2000 Jun; 1(6):545-54. PubMed ID: 10933979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-specific Cre-mediated activation of the diphtheria toxin gene in pituitary tumor cells: potential for cytotoxic gene therapy.
    Lee EJ; Jameson JL
    Hum Gene Ther; 2002 Mar; 13(4):533-42. PubMed ID: 11874631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus-mediated tBid overexpression results in therapeutic effects on p53-resistant hepatocellular carcinoma.
    Miao J; Chen GG; Chun SY; Yun JP; Chak EC; Ho RL; Lai PB
    Int J Cancer; 2006 Oct; 119(8):1985-93. PubMed ID: 16708390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy utilizing the Cre/loxP system selectively suppresses tumor growth of disseminated carcinoembryonic antigen-producing cancer cells.
    Goto H; Osaki T; Kijima T; Nishino K; Kumagai T; Funakoshi T; Kimura H; Takeda Y; Yoneda T; Tachibana I; Hayashi S
    Int J Cancer; 2001 Nov; 94(3):414-9. PubMed ID: 11745423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of the Cre recombinase/loxP system further enhances antitumor effects in cell type-specific gene therapy against carcinoembryonic antigen-producing cancer.
    Kijima T; Osaki T; Nishino K; Kumagai T; Funakoshi T; Goto H; Tachibana I; Tanio Y; Kishimoto T
    Cancer Res; 1999 Oct; 59(19):4906-11. PubMed ID: 10519403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted gene therapy toward astrocytoma using a Cre/loxP-based adenovirus system.
    Maeda M; Namikawa K; Kobayashi I; Ohba N; Takahara Y; Kadono C; Tanaka A; Kiyama H
    Brain Res; 2006 Apr; 1081(1):34-43. PubMed ID: 16529724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoembryonic antigen-specific suicide gene therapy of cytosine deaminase/5-fluorocytosine enhanced by the cre/loxP system in the orthotopic gastric carcinoma model.
    Ueda K; Iwahashi M; Nakamori M; Nakamura M; Matsuura I; Yamaue H; Tanimura H
    Cancer Res; 2001 Aug; 61(16):6158-62. PubMed ID: 11507067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
    Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
    Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of CD133-Sustained Chemoresistant Cancer Stem-Like Cells in Human Ovarian Carcinoma.
    Liu CL; Chen YJ; Fan MH; Liao YJ; Mao TL
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potent oncolytic adenovirus selectively blocks the STAT3 signaling pathway and potentiates cisplatin antitumor activity in ovarian cancer.
    Han Z; Hong Z; Gao Q; Chen C; Hao Z; Ji T; Hu W; Yan Y; Feng J; Liao S; Wu P; Wang D; Wang S; Zhou J; Ma D
    Hum Gene Ther; 2012 Jan; 23(1):32-45. PubMed ID: 21875334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental treatment of ovarian cancers by adenovirus vectors combining receptor targeting and selective expression of tumor necrosis factor.
    Murugesan SR; Akiyama M; Einfeld DA; Wickham TJ; King CR
    Int J Oncol; 2007 Oct; 31(4):813-22. PubMed ID: 17786312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced selective gene expression by adenovirus vector using Cre/loxP regulation system for human carcinoembryonic antigen-producing carcinoma.
    Ueda K; Iwahashi M; Nakamori M; Nakamura M; Yamaue H; Tanimura H
    Oncology; 2000 Sep; 59(3):255-65. PubMed ID: 11053994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus mediated prostate specific enzyme prodrug gene therapy using prostate specific antigen promoter enhanced by the Cre-loxP system.
    Yoshimura I; Ikegami S; Suzuki S; Tadakuma T; Hayakawa M
    J Urol; 2002 Dec; 168(6):2659-64. PubMed ID: 12442005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved Killing of Ovarian Cancer Stem Cells by Combining a Novel Chimeric Antigen Receptor-Based Immunotherapy and Chemotherapy.
    Klapdor R; Wang S; Hacker U; Büning H; Morgan M; Dörk T; Hillemanns P; Schambach A
    Hum Gene Ther; 2017 Oct; 28(10):886-896. PubMed ID: 28836469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-regulatable cancer cell death induced by BID under control of the tissue-specific, lung cancer-targeted TTS promoter system.
    Fukazawa T; Maeda Y; Matsuoka J; Tanaka N; Tanaka H; Durbin ML; Naomoto Y
    Int J Cancer; 2009 Oct; 125(8):1975-84. PubMed ID: 19598260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant adenovirus-mediated overexpression of PTEN and KRT10 improves cisplatin resistance of ovarian cancer in vitro and in vivo.
    Wu H; Wang K; Liu W; Hao Q
    Genet Mol Res; 2015 Jun; 14(2):6591-7. PubMed ID: 26125866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genetically engineered oncolytic adenovirus decoys and lethally traps quiescent cancer stem-like cells in S/G2/M phases.
    Yano S; Tazawa H; Hashimoto Y; Shirakawa Y; Kuroda S; Nishizaki M; Kishimoto H; Uno F; Nagasaka T; Urata Y; Kagawa S; Hoffman RM; Fujiwara T
    Clin Cancer Res; 2013 Dec; 19(23):6495-505. PubMed ID: 24081978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.